2024年5月9日发(作者：帛自)
Nasometer II
Providing objective measures and real-time feedback
in support of an evidence based clinical practice
Providing standardized
measurement of nasalance
Engineered to allow for
accurate data collection
Supports therapy with visual
and auditory feedback
The Nasometer II is a proven clinical tool
used in Cleft and Craniofacial Clinics worldwide
Since its introduction in 1986, the Nasometer has proven to be a useful tool in the evaluation
of nasal resonance and treatment of nasality problems often associated with cleft palate
and other velopharygeal disorders.
Designed to facilitate clinical efficiency
The Nasometer provides a simple, noninvasive method for
obtaining objective measures of nasalance during speech.
It is designed to enable consistent data collection in support
of evidence-based treatment selection.
Numerous clinical studies have shown that nasalance
measures provided by the Nasometer II correlate with
perceptual assessment of nasal resonance
1, 2
The Nasometer II utilizes a convenient set of industry-
validated passages and picture stimuli, which minimizes
variability in application and help produce accurate results
Easily interpret results by comparing patient data
with standardized norms gathered from normal speakers
in dozens of languages, or comparing patient results
pre- and post-treatment
Contributes to improved therapy results
The Nasometer II offers real-time processing enabling immediate
visual and auditory feedback of nasalance measures to facilitate
patients’ acquisition of therapy goals.
Studies have shown that use of the feedback provided
by the Nasometer accelerates a patient’s acquisition of
therapy goals
3
Set patient targets on the nasogram display for a
customized therapy session using powerful visual feedback
The included Nasometer Games module provides fun,
interactive feedback to engage young patients
Patient Passages and Stimuli
Reading Passages Stimuli
•
•
•
•
•
Zoo Passage
Nasal Sentences
Rainbow Passage
Ball Passage (SNAP)
Suzy Passage (SNAP)
SNAP Test Picture Stimuli
•
•
•
•
•
ilabialsB
Alveolars
Velars
Sibilants
Nasals
Provides objective data for an evidence-based practice
Correlates with perceptual assessment of nasality
Contributes to acquisition of therapy goals
Key Studies on Nasometry:
1
Dalston RM, Warren DW, Dalston ET. Use of nasometry as a diagnostic tool for identifying patients
with velopharyngeal impairment. Cleft Palate Craniofac J. 1991 Apr; 28 (2):184-8; discussion 188-9.
Erratum in Cleft Palate Craniofac J 1991 Oct; 28 (4):446.
2
Hardin MA, Van Demark DR, Morris HL, Payne MM. Correspondence between nasalance scores and
listener judgments of hypernasality and hyponasality. Cleft Palate Craniofac J. 1992 Jul; 29 (4):346-51.
3
Fletcher SG, Higgins JM. Performance of children with severe to profound auditory impairment in
instrumentally guided reduction of nasal resonance. Speech Hear Disord.1980 May; 45 (2):181-94.
PENTAX Medical
Americas Head Office
3 Paragon Drive
Montvale, NJ 07645
Phone +1 800 431 5880
Fax +1 201 391 4189
Canadian Head Office
6715 Millcreek Drive, Unit 1
Mississauga, ON L5N 5V2
Phone +1 800 750 5558
Fax +1 905 286 5571
All referenced data was sourced from PENTAX Medical data on file.
Copyright 2016. All Rights Reserved. All company and product names and marks contained within are federally registered trademarks, trademarks, or service
marks of PENTAX of America, Inc. Product specifications are subject to change without notice, and without any obligation on the part of the manufacturer.
MK-789 Rev: A
2024年5月9日发(作者：帛自)
Nasometer II
Providing objective measures and real-time feedback
in support of an evidence based clinical practice
Providing standardized
measurement of nasalance
Engineered to allow for
accurate data collection
Supports therapy with visual
and auditory feedback
The Nasometer II is a proven clinical tool
used in Cleft and Craniofacial Clinics worldwide
Since its introduction in 1986, the Nasometer has proven to be a useful tool in the evaluation
of nasal resonance and treatment of nasality problems often associated with cleft palate
and other velopharygeal disorders.
Designed to facilitate clinical efficiency
The Nasometer provides a simple, noninvasive method for
obtaining objective measures of nasalance during speech.
It is designed to enable consistent data collection in support
of evidence-based treatment selection.
Numerous clinical studies have shown that nasalance
measures provided by the Nasometer II correlate with
perceptual assessment of nasal resonance
1, 2
The Nasometer II utilizes a convenient set of industry-
validated passages and picture stimuli, which minimizes
variability in application and help produce accurate results
Easily interpret results by comparing patient data
with standardized norms gathered from normal speakers
in dozens of languages, or comparing patient results
pre- and post-treatment
Contributes to improved therapy results
The Nasometer II offers real-time processing enabling immediate
visual and auditory feedback of nasalance measures to facilitate
patients’ acquisition of therapy goals.
Studies have shown that use of the feedback provided
by the Nasometer accelerates a patient’s acquisition of
therapy goals
3
Set patient targets on the nasogram display for a
customized therapy session using powerful visual feedback
The included Nasometer Games module provides fun,
interactive feedback to engage young patients
Patient Passages and Stimuli
Reading Passages Stimuli
•
•
•
•
•
Zoo Passage
Nasal Sentences
Rainbow Passage
Ball Passage (SNAP)
Suzy Passage (SNAP)
SNAP Test Picture Stimuli
•
•
•
•
•
ilabialsB
Alveolars
Velars
Sibilants
Nasals
Provides objective data for an evidence-based practice
Correlates with perceptual assessment of nasality
Contributes to acquisition of therapy goals
Key Studies on Nasometry:
1
Dalston RM, Warren DW, Dalston ET. Use of nasometry as a diagnostic tool for identifying patients
with velopharyngeal impairment. Cleft Palate Craniofac J. 1991 Apr; 28 (2):184-8; discussion 188-9.
Erratum in Cleft Palate Craniofac J 1991 Oct; 28 (4):446.
2
Hardin MA, Van Demark DR, Morris HL, Payne MM. Correspondence between nasalance scores and
listener judgments of hypernasality and hyponasality. Cleft Palate Craniofac J. 1992 Jul; 29 (4):346-51.
3
Fletcher SG, Higgins JM. Performance of children with severe to profound auditory impairment in
instrumentally guided reduction of nasal resonance. Speech Hear Disord.1980 May; 45 (2):181-94.
PENTAX Medical
Americas Head Office
3 Paragon Drive
Montvale, NJ 07645
Phone +1 800 431 5880
Fax +1 201 391 4189
Canadian Head Office
6715 Millcreek Drive, Unit 1
Mississauga, ON L5N 5V2
Phone +1 800 750 5558
Fax +1 905 286 5571
All referenced data was sourced from PENTAX Medical data on file.
Copyright 2016. All Rights Reserved. All company and product names and marks contained within are federally registered trademarks, trademarks, or service
marks of PENTAX of America, Inc. Product specifications are subject to change without notice, and without any obligation on the part of the manufacturer.
MK-789 Rev: A